Ankit Mahadevia
Equibles does not estimate personal net worth.
About Ankit Mahadevia
Ankit Mahadevia was last confirmed as Chairman at Spero Therapeutics, Inc. (SPRO) in a filing dated April 16, 2024. Ankit Mahadevia was last confirmed as CEO at Spero Therapeutics, Inc. (SPRO) in a filing dated August 5, 2022. Earlier roles on record: Board Member at Spero Therapeutics, Inc. (SPRO) until January 30, 2026. Spero Therapeutics, Inc. reported in an 8-K filed January 30, 2026 that Ankit Mahadevia resigned as Board of Directors, effective January 30, 2026. The proxy statement of Spero Therapeutics, Inc. reports total compensation of $2,385,905 for Ankit Mahadevia in fiscal 2023, including a base salary of $379,220. Disclosed compensation is on record for 6 fiscal years.
“On January 30, 2026, Ankit Mahadevia, MD notified the Board of Directors (the "Board") of Spero Therapeutics, Inc. (the "Company") of his intention to resign from the Board, including from his service on the Development Committee of the Board and from all officer and director positions he holds with any and all subsidiaries of the Company, effective as of January 30, 2026.”
Affiliation history
-
Start not stated–2024-04-16
Last confirmed by a filing; no departure on record
-
Start not stated–2022-08-05
Last confirmed by a filing; no departure on record
-
Start not stated–2026-01-30
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Spero Therapeutics, Inc. (SPRO) | Former President and Chief Executive Officer | $379,220 | $2,385,905 |
| 2022 | Spero Therapeutics, Inc. (SPRO) | Former President and Chief Executive Officer | $633,750 | $4,239,705 |
| 2021 | Spero Therapeutics, Inc. (SPRO) | Former President and Chief Executive Officer | $590,417 | $4,875,045 |
| 2020 | Spero Therapeutics, Inc. (SPRO) | Chief Executive Officer | $536,667 | $2,120,788 |
| 2019 | Spero Therapeutics, Inc. (SPRO) | Chief Executive Officer | $497,083 | $1,789,374 |
| 2018 | Spero Therapeutics, Inc. (SPRO) | Chief Executive Officer | $465,000 | $721,324 |